Antigenic repertoire of Plasmodium vivax transmission-blocking vaccine candidates from the Indian subcontinent

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Prajapati, Surendra K ^a   Joshi, Hema ^a   Dua, Virendra K ^a  

^a NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MALARIA VACCINE; PVS25 ANTIGEN; PVS28 ANTIGEN; UNCLASSIFIED DRUG; MEMBRANE ANTIGEN; PARASITE ANTIGEN; PROTOZOAL DNA; PVS25 PROTEIN, P VIVAX; PVS28 PROTEIN, P VIVAX;

AMINO ACID SUBSTITUTION; ANTIGENICITY; ANTIMALARIAL ACTIVITY; ARTICLE; BANGLADESH; BRAZIL; COLOMBIA; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA SEQUENCE; EL SALVADOR; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HONDURAS; INDIA; INDONESIA; IRAN; MEXICO; MICROBIAL GENETICS; NICARAGUA; NONHUMAN; NORTH KOREA; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; POPULATION GENETIC STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA; TANDEM REPEAT; THAILAND; TURKEY (REPUBLIC); VIET NAM; CHEMISTRY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS;

AMINO ACID SUBSTITUTION; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; DNA, PROTOZOAN; GENOTYPE; HAPLOTYPES; HUMANS; INDIA; MALARIA VACCINES; MOLECULAR SEQUENCE DATA; PLASMODIUM VIVAX; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 79955376321     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-111     Document Type: Article

References (27)

1. Annual Report. WHO, World Health Organization, Geneva 2008
2. Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. BB Andrade A Reis-Filho SM Souza-Neto J Clarencio LM Camargo A Barral M Barral-Netto, Malar J 2010 9 13 10.1186/1475-2875-9-13 20070895
3. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. DK Kochar A Das SK Kochar V Saxena P Sirohi S Garg A Kochar MP Khatri V Gupta, Am J Trop Med Hyg 2009 80 194 198 19190212
4. Plasmodium vivax malaria. DK Kochar V Saxena N Singh SK Kochar SV Kumar A Das, Emerg Infect Dis 2005 11 132 134 15705338 (Pubitemid 40093368)
5. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. B Genton V D'Acremont L Rare K Baea JC Reeder MP Alpers I Muller, PLoS Med 2008 5 127 10.1371/journal.pmed.0050127 18563961
6. Severe vivax malaria: newly recognised or rediscovered. SJ Rogerson R Carter, PLoS Med 2008 5 136 10.1371/journal.pmed.0050136 18563965
7. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. E Tjitra NM Anstey P Sugiarto N Warikar E Kenangalem M Karyana DA Lampah RN Price, PLoS Med 2008 5 128 10.1371/journal.pmed.0050128 18563962
8. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. PJ Barr KM Green HL Gibson IC Bathurst IA Quakyi DC Kaslow, J Exp Med 1991 174 1203 1208 10.1084/jem.174.5.1203 1940798
9. Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose. DC Kaslow J Shiloach, Biotechnology (NY) 1994 12 494 499 10.1038/nbt0594-494 (Pubitemid 24145177)
10. A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines. PE Duffy DC Kaslow, Infect Immun 1997 65 1109 1113 9038325 (Pubitemid 27088019)
11. Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice. MM Gozar VL Price DC Kaslow, Infect Immun 1998 66 59 64 9423839
12. Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes. H Hisaeda AW Stowers T Tsuboi WE Collins JS Sattabongkot N Suwanabun M Torii DC Kaslow, Infect Immun 2000 68 6618 6623 10.1128/IAI.68.12.6618-6623.2000 11083773 (Pubitemid 32463362)
13. Burden of malaria in India: retrospective and prospective view. A Kumar N Valecha T Jain AP Dash, Am J Trop Med Hyg 2007 77 69 78 18165477
14. Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates. T Tsuboi DC Kaslow MM Gozar M Tachibana YM Cao M Torii, Mol Med 1998 4 772 782 9990863 (Pubitemid 29180124)
15. A rapid genotyping method for the vivax malaria transmission-blocking vaccine candidates, Pvs25 and Pvs28. T Tsuboi O Kaneko YM Cao M Tachibana Y Yoshihiro T Nagao H Kanbara M Torii, Parasitol Int 2004 53 211 216 10.1016/j.parint.2004.01.012 15468527 (Pubitemid 38622622)
16. A monkey's tale: the origin of Plasmodium vivax as a human malaria parasite. AA Escalante OE Cornejo DE Freeland AC Poe E Durrego WE Collins AA Lal, Proc Natl Acad Sci USA 2005 102 1980 1985 10.1073/pnas.0409652102 15684081 (Pubitemid 40261998)
17. Sequence variation of ookinete surface proteins Pvs25 and Pvs28 of Plasmodium vivax isolates from Southern Mexico and their association to local anophelines infectivity. L Gonzalez-Ceron A Alvarado-Delgado J Martinez-Barnetche MH Rodriguez M Ovilla-Munoz F Perez JE Hernandez-Avila MA Sandoval C Rodriguez Mdel C Villarreal-Trevino, Infect Genet Evol 2010 10 645 654 10.1016/j.meegid.2010.03.014 20363376
18. Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran. S Zakeri S Razavi ND Djadid, Acta Trop 2009 109 176 180 10.1016/j.actatropica.2008.09.012 18950597
19. Sequence polymorphisms of Plasmodium vivax ookinete surface proteins (Pvs25 and Pvs28) from clinical isolates in Korea. ET Han WJ Lee J Sattabongkot JW Jang MH Nam SS An I Suh CS Lim, Trop Med Int Health 2010
20. Blocking of transmission to mosquitoes by antibody to Plasmodium vivax malaria vaccine candidates Pvs25 and Pvs28 despite antigenic polymorphism in field isolates. J Sattabongkot T Tsuboi H Hisaeda M Tachibana N Suwanabun T Rungruang YM Cao AW Stowers J Sirichaisinthop RE Coleman M Torii, Am J Trop Med Hyg 2003 69 536 541 14695092 (Pubitemid 38248256)
21. Allelic dimorphism of Plasmodium vivax gam-1 in the Indian subcontinent. SK Prajapati A Verma T Adak RS Yadav A Kumar A Eapen MK Das N Singh SK Sharma MA Rizvi AP Dash H Joshi, Malar J 2006 5 90 10.1186/1475-2875-5-90 17062127
22. Macrogen Inc. Korea. http://www.macrogen.com
23. Arlequin (version 3.0): an integrated software package for population genetics data analysis. L Excoffier G Laval S Schneider, Evol Bioinform Online 2005 1 47 50 19325852
24. Molecular epidemiology of Plasmodium vivax anti-folate resistance in India. SK Prajapati H Joshi V Dev VK Dua, Malar J 2011 10 102 10.1186/1475-2875-10-102 21513569
25. Genetic variations of the dihydrofolate reductase gene of Plasmodium vivax in Mandalay Division, Myanmar. BK Na HW Lee SU Moon TS In K Lin M Maung GT Chung JK Lee TS Kim Y Kong, Parasitol Res 2005 96 321 325 10.1007/s00436-005- 1364-0 15924223 (Pubitemid 40941823)
26. Mutations in the antifolate-resistance-associated genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium vivax isolates from malaria-endemic countries. F Lu CS Lim DH Nam K Kim K Lin TS Kim HW Lee JH Chen Y Wang J Sattabongkot ET Han, Am J Trop Med Hyg 2010 83 474 479 10.4269/ajtmh.2010.10-0004 20810806
27. Bionomics, taxonomy, and distribution of the major malaria vector taxa of Anopheles subgenus Cellia in Southeast Asia: an updated review. S Manguin C Garros I Dusfour RE Harbach M Coosemans, Infect Genet Evol 2008 8 489 503 10.1016/j.meegid.2007.11.004 18178531